HIV I: Molecular Biology and Pathogenesis: Clinical Applications: 49 (Advances in Pharmacology)
Levy , J. Second Ed. American Society of Microbiology. DC , Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics. Group T An infectious molecularclone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1.
HIV I: Molecular Biology and Pathogenesis: Clinical Applications: 49 (Advances in Pharmacology)
J Virol ; 6 : — Identification of a major co-receptor for primary isolates of HIV Nature ; : — Reservoirs for HIVmechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol ; 18 : — HIV-1 biological phenotype inlong-term infected individuals evaluatedwith an MT-2cocultivation assay.
Possible viral cause of multiple sclerosis. In: ViralInfections of the Nervous System. Philadelphia : Lippincott-Raven , : — Power , C. Retroviral diseases of the nervous system: pathogenichost response or viral gene-mediated neurovirulence? Trends Neurosci ; 24 : — Dual infection of thecentral nervous system by AIDS viruses with distinct cellulartropisms. Science ; : — Human immunodeficiencyvirus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects.
J Infect Dis ; : — Budka , H. Neuropathology of human immunodeficiency virusinfection. Brain Pathol ; 1 : — Haase , AT. Pathogenesis of lentivirus infections. J Neuropathol Exp Neurol ; 54 : — Latent reservoirs of HIV: obstacles to theeradication of virus.
Comparisons of HIV-1 viralsequences in brain, choroid plexus and spleen: Potential role of choroid plexus in the pathogenesis of HIV encephalitis. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.
J Virol ; 74 : — Isolates of humanimmunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Sequence analysis of the V3loop in brain and spleen of patients with HIV encephalitis. Demented andnondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol ; 68 : — Cerebrospinal fluid betachemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.
- Chel & Riley Adventures: The Great Mountain Adventure!
- Die geistlichen Fürsten und das Lehnwesen (German Edition)?
- Soffre il mio cor con pace, No. 2 from Mitridate, r? di Ponto, Act 1, K74a (K87) (Full Score)?
- Les Chroniques des Terres Perdues - Nemo (French Edition).
The role of the blood-brainbarrier in HIV infection of the central nervous system. Adv Neuroimmunol ; 4 : — Relationshipbetween human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol ; 42 : — Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.
Ann Neurol ; 39 : — Pattern of involvement resembling a multisystemdegeneration. Acta Neuropathol ; 80 : — Cellular reservoirs of HIV-1in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS ; 10 : — In situ detection ofpolymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system.
Am J Pathol ; : — HIV-1 infection of humanbrain-derived microvascular endothelial cells in vitro. Human immunodeficiencyvirus in brain biopsies of patients with AIDS and progressiveencephalopathy. HIV-1 infectioninduces differentiation of immature neural cells through autocrine tumor necrosis factor and nitric oxide production.
Virology ; : — HIV-1 infection of primaryhuman neuroblasts. Science ; Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Distinct HIV-1 envsequences are associated with neurotropism and neurovirulence. Curr Top Microbiol Immunol ; : 89 — Infection of brainmicroglial cells by human immunodeficiency virus type 1 is CD4 dependent.
J Virol ; 65 : — V3 recombinants indicate acentral role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1. J Virol ; 73 : — Infection of primary humanmicroglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differentialtropism.
New Research In
J Virol ; 70 : — Macrophage-tropic humanimmunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involvedin cell tropism. J Virol ; 66 : — Structure of an HIV gpenvelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Chemokines andreceptors in HIV encephalitis.
AIDS ; 12 : — Lymphotropic virionsaffect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. Kaul , M , Lipton , SA. Chemokines and activated macrophages inHIV gpinduced neuronal apoptosis. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Characterization of a novel binding sitefor the human immunodeficiency virus type 1 envelope proteingp on human fetal astrocytes.
Identification of humanimmunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, andmacrophages. Macrophagetropism determinants of human immunodeficiency virus type 1in vivo. Mosaic structure of thehuman immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations. Neuroimmunomodulation ; 5 : — Expression directed fromHIV long terminal repeats in the central nervous system of transgenic mice.
- HIV I: Molecular Biology and Pathogenesis: Clinical Applications: 49 (Advances in Pharmacology).
- Clinical use of CCR5 inhibitors in HIV and beyond!
- Novak Djokovic - Sein Weg zur Nummer eins (German Edition).
- Mangiferin: An effective therapeutic agent against several disorders (Review).
- The pharmacogenomics of HIV therapy | The Pharmacogenomics Journal.
In vivocompartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsytissues. J Virol ; 71 : — Human immunodeficiencyVirus type 1 Clade A and neurotropism: molecular evolution, recombination and co-receptor utilization. Virology ; : 19 — Human immunodeficiencyvirus type 1 subtypes differ in disease progression. J Infect Dis ; : 68 — Virtues ofbeing faithful: can we limit the genetic variation in human immunodeficiency virus? J Mol Med ; 76 : — Emerging cytopathic andantigenic simian immunodeficiency virus variants influence AIDS progression.
Nat Med ; 5 : — Investigation of the dynamics ofthe spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gagand env genes. Neurovirulence in felineimmunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression. J Virol ; 72 : — Neurologicalabnormalities associated with feline immunodeficiency virusinfection. J Gen Virol ; 75 : — Pathogenesis ofsimian immunodeficiency virus encephalitis: viral determinantsof neurovirulence. Neurovirulentsimian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and invitro.
Lentiviral infection in thebrain induce matrix metalloproteinase expression: the role of envelope diversity. Neuronal death induced bybrain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDSpatients. J Neurovirology ; 6 : — Apoptosis induced by infection ofprimary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope.
Nath , A , Geiger , J. Neurobiological aspects of humanimmunodeficiency virus infection: neurotoxic mechanisms. ProgNeurobiol ; 54 : 19 — HIV-1 coat proteinneurotoxicity prevented by calcium channel antagonists.
Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine | SpringerLink
Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp antibodies but notby anti-CD4 antibodies. Neurology ; 40 : — Neuroscience ; 76 : — The envelope glycoprotein ofhuman immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. The human immunodeficiencyvirus-1 envelope protein gp binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus.
Neuroscience ; 87 : — Seminars in medicine of the Beth IsraelHospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. The changing landscape of ischaemicbrain injury mechanisms. Nature ; : A7-A Lipton , SA. Memantine prevents HIV coat protein-inducedneuronal injury in vitro. HIV-1 gpinduced neurotoxicity to midbrain dopamine cultures. Brain Res ; : — Humanimmunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Central nervoussystem damage produced by expression of the HIV-1 coat protein gp in transgenic mice.
J Biol Chem ; : — HIV glycoprotein enhances intercellular adhesion molecule-1 gene expression in glial cells. J Immunol ; : — Identification of a humanimmunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic.
The Tat protein of HIV-1 inducestumor necrosis factor-alpha production. Implications for HIVassociated neurological diseases. Transient exposure to HIV-1 Tatprotein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. HIV-1 Tat neurotoxicity isprevented by matrix metalloproteinase inhibitors. Ann Neurol ; 49 : — Decay characteristics ofHIVinfected compartments during combination therapy. Cerebrospinal fluid humanimmunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome.
Neurology ; 54 : — Quantitation of humanimmunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Humanimmunodeficiency virus type 1 DNA and RNA load in brains of demented and nondemented patients with acquired immunodeficiency syndrome. J Neurovirol ; 3 : — Ann Neurol ; 36 : 32 — AnnNeurol ; 38 : — Low levels ofhuman immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndromeencephalopathy.
Gonzalez-Scarano , F , Baltuch , G. Microglia as mediators ofinflammatory and degenerative diseases. Annu Rev Neurosci ; 22 : — Secretion of neurotoxins bymononuclear phagocytes infected with HIV Humanimmunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations incultured human brains. J Clin Invest ; 87 : — Tardieu , M , Janabi , N. HIV-1 and the developing human nervoussystem: in vivo and in vitro aspects. Dev Neurosci ; 16 : — Theneuropathogenesis of the AIDS dementia complex.